Featuring a slide presentation and related discussion from Dr Amrita Krishnan, including the following topics:
- Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
- Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
- Belantamab mafodotin in combination with pomalidomide; recent data and ongoing trials with BCMA-targeted bispecific antibodies (7:30)
- BCMA-targeted CAR (chimeric antigen receptor) T-cell therapies under evaluation for MM (17:07)
CME information and select publications